Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY:TMO)

492.72 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Price Over Earnings Overview: Thermo Fisher Scientific
 
Via Benzinga
Thermo Fisher Scientific to Participate in J.P. Morgan CEO Call Series on September 5, 2025
From Thermo Fisher Scientific Inc.
Via Business Wire
1 S&P 500 Stock to Target This Week and 2 We Avoid
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
Navigating the Economic Crosscurrents: GDP Soars, But Inflationary Pressures Persist
The U.S. economy finds itself at a critical juncture, exhibiting a robust rebound in Gross Domestic Product (GDP) growth while simultaneously grappling with persistent and, in some areas, accelerating... 
Via MarketMinute
Topics Artificial Intelligence Economy Energy
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Spotting Winners: Thermo Fisher (NYSE:TMO) And Research Tools & Consumables Stocks In Q2
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Thermo Fisher (NYSE:TMO) and its peers. 
Via StockStory
Topics Economy
Why Thermo Fisher Scientific Stock Was Topping the Market Today
According to one pundit, the company has a hard-to-beat mix of quality products and services. 
Via The Motley Fool
Thermo Fisher Positioned As Biopharma's Partner Of Choice
William Blair starts Thermo Fisher with an Outperform rating, citing strong M&A, solid balance sheet, and 22% upside potential by 2026. 
Via Benzinga
This Thermo Fisher Scientific Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
 
Via Benzinga
The Analyst Verdict: Thermo Fisher Scientific In The Eyes Of 10 Experts
 
Via Benzinga
Toast, Amazon, Thermo Fisher Scientific And An Industrial Stock On CNBC's 'Final Trades'
Ritholtz Wealth Management CEO Joshua Brown named Toast his final trade after it reported quarterly earnings of 13 cents per share. 
Via Benzinga
Thermo Fisher, ICU Medical, CONMED, Pediatrix Medical Group, and IQVIA Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed... 
Via StockStory
Topics Bonds Economy Government
Avantor Stock Jumps As Activist Investor Urges Sale, Board Shake-Up, And Cost Cuts
Engine Capital, holding a 3% stake in Avantor, urges the board to pursue a turnaround or sale, citing years of underperformance, missed targets, and lost market share. 
Via Benzinga
Avantor Surges As Activist Investor Takes Aim At 'Self-Inflicted' Issues
The investor is digging in to improve years of share decline, saying the company can improve its cost discipline and turnover. 
Via Investor's Business Daily
Topics Supply Chain
3 Profitable Stocks We Find Risky
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
$1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Avantor Shares Plummet Amidst Broader Market Turmoil and Company-Specific Headwinds
Avantor (NYSE: AVTR) shares have recently experienced a significant and sustained plunge, hitting a 52-week low and reflecting a challenging period for the life sciences company. This sharp decline is... 
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
Looking Into Thermo Fisher Scientific's Recent Short Interest
 
Via Benzinga
3 Hyped Up Stocks We’re Skeptical Of
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to new product launches, positive news, or even a dedicated social media... 
Via StockStory
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
 
Via Benzinga
Thermo Fisher Posts 3% Q2 Rise
Via The Motley Fool
Unpacking the Latest Options Trading Trends in Thermo Fisher Scientific
 
Via Benzinga
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio?
Medpace, ICON, and West Pharma led last week's large-cap rally, driven by strong earnings beats and upgraded guidance. 
Via Benzinga
Topics Earnings
Trade Deals Fuel Wall Street Gains, Trump Renews Fed Attack: This Week In Markets
Wall Street closed the week at record highs, driven by strong earnings, new trade deals, upbeat macro data and Trump's AI and Fed moves. 
Via Benzinga
Topics Artificial Intelligence Economy Government
If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today
 
Via Benzinga
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. 
Via Chartmill
US Stocks Likely To Open On A Mixed Note After Tesla, Alphabet Earnings: Intel, American Airlines, Honeywell In Focus
U.S. stock futures were fluctuating on Thursday after rallying on Wednesday. Futures of major benchmark indices were mixed. 
Via Benzinga
Dow Surges 500 Points Amid Trump's Trade Deal Deluge: Investor Sentiment Improves, Fear Index Moves To 'Extreme Greed' Zone
CNN Money Fear and Greed index rose to Extreme Greed zone on Wednesday. US-Japan pact raises baseline tariff to 15% 
Via Benzinga
Topics Government Stocks World Trade
TMO Q2 Deep Dive: Pharma Strength, Tariff Adaptation, and Strategic Investments Shape Outlook
Life sciences company Thermo Fisher (NYSE:TMO) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 3% year on year to $10.86 billion. Its non-GAAP profit of $5.36 per... 
Via StockStory
Topics Artificial Intelligence World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.